US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mineralys Therapeutics, Inc.

14.52

+0.39002.76%

Post-market: 14.520.00000.00%16:20 EDT

Volume:937.80K

Turnover:13.62M

Market Cap:946.35M

PE:-4.16

High:15.00

Open:14.17

Low:14.16

Close:14.13

52wk High:18.38

52wk Low:8.24

Shares:65.18M

Float Shares:43.59M

Volume Ratio:0.94

T/O Rate:2.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4926

EPS(LYR):-3.6632

ROE:-56.31%

ROA:-35.87%

PB:2.77

PE(LYR):-3.96

Loading ...

Overview Company News Filings

Chief Medical Officer David Malcom Rodman Reports Disposal of Mineralys Therapeutics Inc. Common Shares

Positive Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Lorundrostat Outcomes and Strong Financial Position

Mineralys Therapeutics Q2 GAAP Loss Narrows

MT Newswires Live

Mineralys Therapeutics Announces Positive Results from Key Hypertension Trials and Prepares for FDA Pre-NDA Meeting in 4Q 2025

Mineralys Therapeutics Q2 EPS $(0.66) Beats $(0.74) Estimate

BRIEF-Mineralys Therapeutics Q2 EPS USD -0.66

Mineralys Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview

Mineralys Therapeutics CFO & Secretary Adam Levy Sells 36% Of Holding

Simply Wall St.

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

CFO Adam Scott Levy Reports Disposal of Common Shares of Mineralys Therapeutics Inc

Chief Medical Officer David Malcom Rodman Reports Disposal of Mineralys Therapeutics Inc. Common Shares

Mineralys Therapeutics, Inc. (MLYS) Receives a Hold from Jefferies

Mineralys Therapeutics Announces Positive Results from Phase 2 Explore-CKD Trial of Lorundrostat for Hypertension Treatment

Mineralys Therapeutics Inc. Chief Medical Officer David Rodman Reports Disposal of Common Shares

Jefferies Initiates Coverage on Mineralys Therapeutics With Hold Rating, $15 Price Target

MT Newswires Live

Cautious Outlook for Mineralys Therapeutics Amid Market Challenges and Competitive Pressures

Mineralys announces late-breaking presentation of data from Launch-HTN trial

BRIEF-Mineralys Therapeutics Inc Says Lorundrostat Shows 16.9 Mmhg Reduction At Week 6, 19.0 Mmhg At Week 12

Mineralys Therapeutics Inc. Conducted Annual Stockholder Meeting

BRIEF-Mineralys Announces Late-Breaking Presentation Of Phase 3 Launch-HTN Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MLYS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":14.52,"timestamp":1755288000000,"preClose":14.13,"halted":0,"volume":937798,"hourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.52,"latestTime":"16:20 EDT","volume":8793,"amount":127674.36,"timestamp":1755289200626},"delay":0,"floatShares":43593083,"shares":65175287,"eps":-3.492646,"marketStatus":"Market Closed","change":0.39,"latestTime":"08-15 16:00:00 EDT","open":14.17,"high":15,"low":14.16,"amount":13616465.931253,"amplitude":0.059448,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.492646,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":14.13,"preHourTrading":{"tag":"盘前","latestPrice":14.13,"preClose":14.13,"latestTime":"08:59 EDT","volume":1038,"amount":14754.789053999999,"timestamp":1755262752341},"postHourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.52,"latestTime":"16:20 EDT","volume":8793,"amount":127674.36,"timestamp":1755289200626},"volumeRatio":0.9369098096222764,"impliedVol":1.0319,"impliedVolPercentile":0.764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":43593083,"roa":"-35.87%","roe":"-56.31%","lyrEps":-3.663179,"volumeRatio":0.9369098096222764,"shares":65175287,"dividePrice":0,"high":15,"amplitude":0.059448,"preClose":14.13,"low":14.16,"week52Low":8.241,"pbRate":"2.77","week52High":18.38,"institutionHeld":0,"latestPrice":14.52,"eps":-3.492646,"divideRate":0,"volume":937798,"delay":0,"ttmEps":-3.492646,"open":14.17,"prevYearClose":12.31,"prevWeekClose":13,"prevMonthClose":14.15,"prevQuarterClose":13.53,"fiveDayClose":13,"twentyDayClose":14.23,"sixtyDayClose":16.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"MLYS","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MLYS","fiscalQuarterEnding":"2025/03","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2025-02-12","symbol":"MLYS","fiscalQuarterEnding":"2024/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.98},{"market":"US","date":"2024-11-11","symbol":"MLYS","fiscalQuarterEnding":"2024/09","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731301200000,"reportTimeType":"post","actualEps":-1.13},{"market":"US","date":"2024-08-13","symbol":"MLYS","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1749614400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2025-08-15","current":-4.827344,"percent":0.786517,"low":-28.120261,"twenty":-13.761419,"median":-6.586232,"eighty":-4.762827,"high":-2.455206,"avg":-9.231285,"sd":6.105764,"marketCap":920926805},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.982663,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":634011855},{"date":"2024-06-07","current":-7.18498,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":652381815},{"date":"2024-06-14","current":-6.878771,"twenty":-18.699239,"median":-12.004794,"eighty":-7.147798,"marketCap":624578633},{"date":"2024-06-21","current":-6.583498,"twenty":-18.674036,"median":-11.801366,"eighty":-7.108428,"marketCap":597768421},{"date":"2024-06-28","current":-6.397585,"twenty":-18.632904,"median":-11.587276,"eighty":-7.004535,"marketCap":580887918},{"date":"2024-07-05","current":-6.796751,"twenty":-18.599998,"median":-11.08918,"eighty":-6.90283,"marketCap":617131352},{"date":"2024-07-12","current":-7.917695,"twenty":-18.591772,"median":-11.014903,"eighty":-6.90283,"marketCap":718910859},{"date":"2024-07-19","current":-7.217788,"twenty":-18.588966,"median":-10.834579,"eighty":-6.932357,"marketCap":655360728},{"date":"2024-07-26","current":-7.354489,"twenty":-18.580102,"median":-10.505451,"eighty":-6.973914,"marketCap":667772863},{"date":"2024-08-02","current":-6.468669,"twenty":-18.558077,"median":-10.192372,"eighty":-6.88752,"marketCap":587342228},{"date":"2024-08-09","current":-6.025759,"twenty":-18.551128,"median":-10.024815,"eighty":-6.843776,"marketCap":547126910},{"date":"2024-08-16","current":-4.076332,"twenty":-18.496301,"median":-9.845949,"eighty":-6.771136,"marketCap":487818681},{"date":"2024-08-23","current":-4.824282,"twenty":-18.473334,"median":-9.694629,"eighty":-6.684109,"marketCap":577326696},{"date":"2024-08-30","current":-5.156705,"twenty":-18.446961,"median":-9.491619,"eighty":-6.64802,"marketCap":617108036},{"date":"2024-09-06","current":-4.666382,"twenty":-18.432727,"median":-9.462603,"eighty":-6.602089,"marketCap":558430560},{"date":"2024-09-13","current":-4.886612,"twenty":-18.41079,"median":-9.366766,"eighty":-6.532417,"marketCap":584785698},{"date":"2024-09-20","current":-4.865835,"twenty":-18.393266,"median":-9.226167,"eighty":-6.400866,"marketCap":582299364},{"date":"2024-09-27","current":-4.944786,"twenty":-18.318529,"median":-9.18084,"eighty":-6.305758,"marketCap":591747432},{"date":"2024-10-04","current":-5.767531,"twenty":-18.250509,"median":-9.070536,"eighty":-6.252,"marketCap":690206249},{"date":"2024-10-11","current":-5.634562,"twenty":-18.229399,"median":-9.042924,"eighty":-6.143869,"marketCap":674293713},{"date":"2024-10-18","current":-5.983606,"twenty":-18.210635,"median":-8.998552,"eighty":-6.048725,"marketCap":716064120},{"date":"2024-10-25","current":-5.655339,"twenty":-18.194216,"median":-8.973895,"eighty":-5.961361,"marketCap":676780046},{"date":"2024-11-01","current":-5.588854,"twenty":-18.189525,"median":-8.92105,"eighty":-5.849535,"marketCap":668823778},{"date":"2024-11-08","current":-5.834016,"twenty":-18.182489,"median":-8.908316,"eighty":-5.825113,"marketCap":698162517},{"date":"2024-11-15","current":-3.728112,"twenty":-18.13003,"median":-8.863447,"eighty":-5.784153,"marketCap":571344320},{"date":"2024-11-22","current":-4.056108,"twenty":-18.054477,"median":-8.834854,"eighty":-5.738445,"marketCap":621610675},{"date":"2024-11-29","current":-4.147037,"twenty":-18.011266,"median":-8.824542,"eighty":-5.694398,"marketCap":635545903},{"date":"2024-12-06","current":-4.289927,"twenty":-17.971392,"median":-8.704678,"eighty":-5.652845,"marketCap":657444117},{"date":"2024-12-13","current":-3.864506,"twenty":-17.93941,"median":-8.597282,"eighty":-5.622096,"marketCap":592247161},{"date":"2024-12-20","current":-4.007395,"twenty":-17.918728,"median":-8.45617,"eighty":-5.566415,"marketCap":614145375},{"date":"2024-12-27","current":-4.163275,"twenty":-17.89399,"median":-8.38318,"eighty":-5.386048,"marketCap":638034336},{"date":"2025-01-03","current":-4.140542,"twenty":-17.884608,"median":-8.283595,"eighty":-5.230583,"marketCap":634550529},{"date":"2025-01-10","current":-3.205267,"twenty":-17.865843,"median":-8.193856,"eighty":-5.186749,"marketCap":491216763},{"date":"2025-01-17","current":-3.000675,"twenty":-17.75795,"median":-8.130978,"eighty":-5.093743,"marketCap":459862501},{"date":"2025-01-24","current":-3.237742,"twenty":-17.725112,"median":-7.972375,"eighty":-5.030384,"marketCap":496193629},{"date":"2025-01-31","current":-3.344909,"twenty":-17.66738,"median":-7.925786,"eighty":-4.98717,"marketCap":512617290},{"date":"2025-02-07","current":-3.185782,"twenty":-17.600622,"median":-7.886161,"eighty":-4.961636,"marketCap":488230642},{"date":"2025-02-14","current":-2.870012,"twenty":-17.57969,"median":-7.841803,"eighty":-4.929578,"marketCap":510316922},{"date":"2025-02-21","current":-2.679426,"twenty":-17.570308,"median":-7.800135,"eighty":-4.913205,"marketCap":476428689},{"date":"2025-02-28","current":-2.56171,"twenty":-17.532779,"median":-7.76156,"eighty":-4.879413,"marketCap":455497722},{"date":"2025-03-07","current":-2.948489,"twenty":-17.497596,"median":-7.666927,"eighty":-4.847705,"marketCap":524270901},{"date":"2025-03-14","current":-5.032788,"twenty":-17.464759,"median":-7.556805,"eighty":-4.833314,"marketCap":894880035},{"date":"2025-03-21","current":-6.142597,"twenty":-17.410812,"median":-7.474785,"eighty":-4.837364,"marketCap":1092215135},{"date":"2025-03-28","current":-5.337906,"twenty":-17.394393,"median":-7.420413,"eighty":-4.839437,"marketCap":949133010},{"date":"2025-04-04","current":-4.515009,"twenty":-17.356865,"median":-7.381829,"eighty":-4.839437,"marketCap":802813733},{"date":"2025-04-11","current":-4.88916,"twenty":-17.298227,"median":-7.359957,"eighty":-4.826979,"marketCap":869341455},{"date":"2025-04-17","current":-4.870916,"twenty":-17.237243,"median":-7.346287,"eighty":-4.83217,"marketCap":866097643},{"date":"2025-04-25","current":-4.867268,"twenty":-17.117621,"median":-7.217788,"eighty":-4.83083,"marketCap":865448881},{"date":"2025-05-02","current":-5.626182,"twenty":-17.049602,"median":-7.174044,"eighty":-4.83217,"marketCap":1000391435},{"date":"2025-05-09","current":-5.345238,"twenty":-17.026147,"median":-7.146704,"eighty":-4.837056,"marketCap":950436740},{"date":"2025-05-16","current":-5.307011,"twenty":-16.932326,"median":-7.108428,"eighty":-4.838863,"marketCap":1000440655},{"date":"2025-05-23","current":-5.642373,"twenty":-16.739993,"median":-7.070152,"eighty":-4.844431,"marketCap":1063660683},{"date":"2025-05-30","current":-5.414189,"twenty":-16.571115,"median":-7.048279,"eighty":-4.857525,"marketCap":1020644994},{"date":"2025-06-06","current":-5.40036,"twenty":-16.559387,"median":-6.993599,"eighty":-4.86168,"marketCap":1018037982},{"date":"2025-06-13","current":-5.158346,"twenty":-16.512477,"median":-6.906111,"eighty":-4.865835,"marketCap":972415282},{"date":"2025-06-20","current":-4.746923,"twenty":-16.418656,"median":-6.878771,"eighty":-4.854252,"marketCap":894856690},{"date":"2025-06-27","current":-4.840271,"twenty":-16.273234,"median":-6.854165,"eighty":-4.839875,"marketCap":912454018},{"date":"2025-07-03","current":-5.026967,"twenty":-16.102011,"median":-6.815889,"eighty":-4.834459,"marketCap":947648672},{"date":"2025-07-11","current":-5.061541,"twenty":-16.001153,"median":-6.774878,"eighty":-4.830927,"marketCap":954166201},{"date":"2025-07-18","current":-4.95782,"twenty":-15.757219,"median":-6.718225,"eighty":-4.834459,"marketCap":934613615},{"date":"2025-07-25","current":-4.930162,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"marketCap":929399592},{"date":"2025-08-01","current":-4.892131,"twenty":-14.028818,"median":-6.651848,"eighty":-4.823763,"marketCap":922230311},{"date":"2025-08-08","current":-4.449592,"twenty":-13.915218,"median":-6.625405,"eighty":-4.809096,"marketCap":838805943},{"date":"2025-08-15","current":-4.827344,"twenty":-13.761419,"median":-6.586232,"eighty":-4.762827,"marketCap":920926805}],"updateTime":1755413227501},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559671469","title":"Chief Medical Officer David Malcom Rodman Reports Disposal of Mineralys Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559671469","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559671469?lang=en_us&edition=fundamental","pubTime":"2025-08-15 06:03","pubTimestamp":1755209012,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, Chief Medical Officer, reported a disposal of common shares of Mineralys Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL8wszwp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2559046226","title":"Positive Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Lorundrostat Outcomes and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2559046226","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559046226?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:55","pubTimestamp":1755086127,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda has maintained their bullish stance on MLYS stock, giving a Buy rating today. Rami Katkhuda’s rating is based...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-buy-rating-for-mineralys-therapeutics-inc-driven-by-promising-lorundrostat-outcomes-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-buy-rating-for-mineralys-therapeutics-inc-driven-by-promising-lorundrostat-outcomes-and-strong-financial-position-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2559891624","title":"Mineralys Therapeutics Q2 GAAP Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2559891624","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559891624?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:40","pubTimestamp":1755031254,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  reported a Q2 GAAP loss late Tuesday of $0.66 per diluted share, narrowing from a loss of $0.83 a year earlier.Analysts polled by FactSet expected a loss of $0.74.As of June 30, the company had cash, cash equivalents and investments of $324.9 million.The company said its cash reserves can fund clinical trials, regulatory activities and corporate operations into 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4007","BK4139","BK4539","MLYS"],"gpt_icon":0},{"id":"2559621825","title":"Mineralys Therapeutics Announces Positive Results from Key Hypertension Trials and Prepares for FDA Pre-NDA Meeting in 4Q 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559621825","media":"Reuters","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559621825?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:10","pubTimestamp":1755029425,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Announces Positive Results from Key Hypertension Trials and Prepares for FDA Pre-NDA Meeting in 4Q 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL4J3B2l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mineralys Therapeutics Announces Positive Results from Key Hypertension Trials and Prepares for FDA Pre-NDA Meeting in 4Q 2025","news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2559032629","title":"Mineralys Therapeutics Q2 EPS $(0.66) Beats $(0.74) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559032629","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559032629?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:06","pubTimestamp":1755029172,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Q2 EPS $(0.66) Beats $(0.74) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47073788/mineralys-therapeutics-q2-eps-0-66-beats-0-74-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ"],"gpt_icon":0},{"id":"2559629436","title":"BRIEF-Mineralys Therapeutics Q2 EPS USD -0.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629436","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629436?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:05","pubTimestamp":1755029148,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Q2 EPS USD -0.66\n\n\nAug 12 (Reuters) - Mineralys Therapeutics Q2 net income USD -43.274 million.\n\nQ2 operating income USD -46.746 million\nQ2 operating expenses USD 46.746 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nPLX23C1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS"],"gpt_icon":0},{"id":"2558260577","title":"Mineralys Therapeutics Inc  expected to post a loss of 72 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558260577","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558260577?lang=en_us&edition=fundamental","pubTime":"2025-08-09 06:08","pubTimestamp":1754690887,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc  expected to post a loss of72cents a share - Earnings Preview Mineralys Therapeutics Inc MLYS.OQ MLYS.O is expected to  show no change in quarterly revenue when it reports  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U03QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS"],"gpt_icon":0},{"id":"2557969673","title":"Mineralys Therapeutics CFO & Secretary Adam Levy Sells 36% Of Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2557969673","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557969673?lang=en_us&edition=fundamental","pubTime":"2025-08-05 19:07","pubTimestamp":1754392047,"startTime":"0","endTime":"0","summary":"NasdaqGS:MLYS 1 Year Share Price vs Fair Value Explore Mineralys Therapeutics's Fair Values from the Community and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/mineralys-therapeutics-cfo-secretary-adam-levy-sells-36-of-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK4139","MLYS","BK4007","BK4539"],"gpt_icon":0},{"id":"2557343743","title":"Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557343743","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557343743?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:05","pubTimestamp":1754337900,"startTime":"0","endTime":"0","summary":"RADNOR, Pa., Aug.  04, 2025  (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and rela","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/04/3126851/0/en/Mineralys-Therapeutics-to-Announce-Second-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-Tuesday-August-12-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4539","MLYS","BK4181","BK4139","BK4218","BK4588","BK4585","HST"],"gpt_icon":0},{"id":"2555607393","title":"CFO Adam Scott Levy Reports Disposal of Common Shares of Mineralys Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2555607393","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555607393?lang=en_us&edition=fundamental","pubTime":"2025-07-31 08:12","pubTimestamp":1753920751,"startTime":"0","endTime":"0","summary":"Adam Scott Levy, CFO and Secretary of Mineralys Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL84GBCt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2551192276","title":"Chief Medical Officer David Malcom Rodman Reports Disposal of Mineralys Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2551192276","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551192276?lang=en_us&edition=fundamental","pubTime":"2025-07-16 05:01","pubTimestamp":1752613263,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, Chief Medical Officer, reported a disposal of common shares of Mineralys Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL7TxR3l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2551180675","title":"Mineralys Therapeutics, Inc. (MLYS) Receives a Hold from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180675","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551180675?lang=en_us&edition=fundamental","pubTime":"2025-07-14 23:55","pubTimestamp":1752508552,"startTime":"0","endTime":"0","summary":"In a report released today, Dennis Ding from Jefferies reiterated a Hold rating on Mineralys Therapeutics, Inc., with a price target of $15.00. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mineralys-therapeutics-inc-mlys-receives-a-hold-from-jefferies-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mineralys-therapeutics-inc-mlys-receives-a-hold-from-jefferies-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2544690259","title":"Mineralys Therapeutics Announces Positive Results from Phase 2 Explore-CKD Trial of Lorundrostat for Hypertension Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2544690259","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544690259?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:08","pubTimestamp":1750158495,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company, has announced positive topline results from its Phase 2 Explore-CKD trial involving lorundrostat. This trial evaluated the safety and efficacy of a 25 mg dose of lorundrostat in subjects with hypertension and comorbid chronic kidney disease . The trial met its primary endpoint, demonstrating a placebo-adjusted reduction in systolic blood pressure of 7.5 mmHg and a significant reduction in the urine albumin-to-creatinine ratio by 31%. Lorundrostat also showed a favorable safety and tolerability profile. These results have been presented, and a conference call discussing the findings was held on June 17, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineral","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL2zn1Dd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2544988800","title":"Mineralys Therapeutics Inc. Chief Medical Officer David Rodman Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2544988800","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544988800?lang=en_us&edition=fundamental","pubTime":"2025-06-17 04:04","pubTimestamp":1750104242,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, the Chief Medical Officer at Mineralys Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL5YJlh0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Inc. Chief Medical Officer David Rodman Reports Disposal of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2542896585","title":"Jefferies Initiates Coverage on Mineralys Therapeutics With Hold Rating, $15 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2542896585","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542896585?lang=en_us&edition=fundamental","pubTime":"2025-06-11 19:34","pubTimestamp":1749641678,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) has an average rating of Buy and mean price target of $36.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","MLYS"],"gpt_icon":0},{"id":"2542583340","title":"Cautious Outlook for Mineralys Therapeutics Amid Market Challenges and Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2542583340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542583340?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:35","pubTimestamp":1749587713,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc. (MLYS) has received a new Hold rating, initiated by Jefferies analyst, Dennis Ding. Dennis Ding has given his Hold rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-outlook-for-mineralys-therapeutics-amid-market-challenges-and-competitive-pressures-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-outlook-for-mineralys-therapeutics-amid-market-challenges-and-competitive-pressures-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2538105256","title":"Mineralys announces late-breaking presentation of data from Launch-HTN trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2538105256","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538105256?lang=en_us&edition=fundamental","pubTime":"2025-05-26 20:10","pubTimestamp":1748261405,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced detailed results from the pivotal Phase 3 Launch-HTN trial in over 1,000 participants with uncontrolled hyp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-announces-late-breaking-presentation-of-data-from-launch-htn-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-announces-late-breaking-presentation-of-data-from-launch-htn-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2537607201","title":"BRIEF-Mineralys Therapeutics Inc Says Lorundrostat Shows 16.9 Mmhg Reduction At Week 6, 19.0 Mmhg At Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2537607201","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537607201?lang=en_us&edition=fundamental","pubTime":"2025-05-24 16:35","pubTimestamp":1748075748,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Inc Says Lorundrostat Shows 16.9 Mmhg Reduction At Week 6, 19.0 Mmhg At Week 12May 24 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS INC - LORUNDROST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250524:nFWN3RW05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2537593922","title":"Mineralys Therapeutics Inc. Conducted Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537593922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537593922?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:15","pubTimestamp":1747944936,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc. held its annual meeting of stockholders on May 22, 2025. The stockholders voted on two key proposals during the meeting. The first proposal was to elect two directors, Glenn P. Sblendorio and Derek DiRocco, Ph.D., as Class II directors. The second proposal was to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL8LsYks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2536124786","title":"BRIEF-Mineralys Announces Late-Breaking Presentation Of Phase 3 Launch-HTN Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2536124786","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536124786?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:16","pubTimestamp":1747743369,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Announces Late-Breaking Presentation Of Phase 3 Launch-HTN TrialMay 20 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS ANNOUNCES LATE-BREAKING PRESENTATION OF PHASE 3 LAUNCH-HT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RS0TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}